Angioedema Treatment Global Market Report 2025

Description

Angioedema treatment involves the medical management of swelling beneath the skin or mucous membranes, which is often triggered by allergic reactions, side effects of medications, genetic disorders, or sometimes unknown factors. The goal of treatment is to alleviate symptoms, prevent airway blockage, and reduce the frequency and severity of episodes.

The primary categories of angioedema treatment include allergic angioedema, drug-induced angioedema, idiopathic angioedema, and hereditary angioedema. Allergic angioedema results from allergic reactions to substances such as certain foods, insect stings, or medications. Treatments may be delivered via injection or oral administration and are used by various end users, including hospitals, clinics, and research institutions.

The angioedema treatment market research report is one of a series of new reports from The Business Research Company that provides angioedema treatment market statistics, including angioedema treatment industry global market size, regional shares, competitors with an angioedema treatment market share, detailed angioedema treatment market segments, market trends and opportunities, and any further data you may need to thrive in the angioedema treatment industry. This angioedema treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The angioedema treatment market size has grown rapidly in recent years. It will grow from $2.72 billion in 2024 to $3.13 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth observed during the historic period can be attributed to increased government support, higher diagnosis rates, a surge in autoimmune disorders, expansion of clinical trials, and improvements in healthcare infrastructure.

The angioedema treatment market size is expected to see rapid growth in the next few years. It will grow to $5.40 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The projected growth during the forecast period can be linked to rising healthcare expenditure, greater awareness of allergies, an increasing burden of chronic diseases, a higher incidence and prevalence of angioedema, and a growing emphasis on personalized medicine. Key trends expected in this period include advancements in diagnostic technologies, integration of machine learning, increased investments in research and development, the adoption of telemedicine, and accelerated regulatory approvals and market access.

An increase in the incidence of rare diseases is anticipated to drive the growth of the angioedema treatment market in the coming years. Rare diseases are medical conditions that affect a small percentage of the population and often present limited treatment options along with significant health challenges. This rise is largely due to advancements in genetic testing and diagnostic technologies, which enable more accurate identification and diagnosis of conditions that were previously undetected, resulting in a higher reported prevalence. Angioedema treatments play a vital role in managing rare diseases like hereditary angioedema by offering targeted therapies that help prevent and control severe swelling episodes, ultimately enhancing patient outcomes. For example, in November 2024, the U.S. Food and Drug Administration reported that over 7,000 rare diseases affect more than 30 million people in the United States. Thus, the growing incidence of rare diseases is contributing to the expansion of the angioedema treatment market.

Leading companies in the angioedema treatment market are prioritizing the development of innovative solutions, such as subcutaneous injections, to provide more convenient and rapid relief for patients experiencing acute hereditary angioedema (HAE) attacks. Subcutaneous injections deliver medication into the fatty tissue beneath the skin, allowing for gradual absorption into the bloodstream. For example, in April 2025, CSL Limited, an Australia-based biotechnology firm, introduced ANDEMBRY (garadacimab), a novel fully human monoclonal antibody designed to prevent acute HAE attacks. ANDEMBRY is the first pre-filled pen approved for once-monthly subcutaneous administration, offering a convenient long-term prophylactic option. The medication works by inhibiting activated Factor XII (Factor XIIa), a key component in the pathway that triggers angioedema. This innovation marks a major step forward in HAE treatment by delivering effective, patient-focused disease management.

In December 2023, Ionis Pharmaceuticals Inc., a U.S.-based biotechnology company, entered into a partnership with Otsuka Pharmaceutical Co., Ltd. to commercialize donidalorsen in Europe for the treatment of hereditary angioedema (HAE). The goal of this collaboration is to expedite the regulatory approval process and facilitate the launch of donidalorsen in the European market, leveraging Otsuka's regional expertise and established market presence. Otsuka Pharmaceutical Co., Ltd., a Japan-based pharmaceutical firm, provides treatments for hereditary angioedema and will play a key role in making this innovative therapy accessible to patients across Europe.

Major players in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.

North America was the largest region in the angioedema treatment market in 2024. The regions covered in angioedema treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the angioedema treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The angioedema treatment market consists of revenues earned by entities providing services, such as antihistamine administration, diagnostic services, corticosteroid therapy, genetic counseling, and immunology services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Angioedema Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on angioedema treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for angioedema treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The angioedema treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Allergic Angioedema; Drug-Induced Angioedema; Idiopathic Angioedema; Hereditary Angioedema
2) By Route Of Administration: Injection; Oral
3) By End Use: Hospitals; Clinics; Research Organizations
1) By Allergic Angioedema: Antihistamines; Corticosteroids; Epinephrine; Immunotherapy; Allergen Avoidance Therapies
2) By Drug-Induced Angioedema: Discontinuation of Causative Drug; Antihistamines; Corticosteroids; Epinephrine; Bradykinin Pathway Inhibitors
3) By Idiopathic Angioedema: Empirical Antihistamine Therapy; Corticosteroid Therapy; Leukotriene Receptor Antagonists; Monoclonal Antibodies; Observation and Symptom Management
4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy; Bradykinin B2 Receptor Antagonists; Kallikrein Inhibitors; Attenuated Androgens; Antifibrinolytics
Companies Mentioned: Sanofi SA; Takeda Pharmaceutical Company Limited; Viatris Inc.; Otsuka Pharmaceutical Co. Ltd.; Fresenius Kabi AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r35828

1. Executive Summary

2. Angioedema Treatment Market Characteristics

3. Angioedema Treatment Market Trends And Strategies

4. Angioedema Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Angioedema Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Angioedema Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Angioedema Treatment Market Growth Rate Analysis
5.4. Global Angioedema Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Angioedema Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Angioedema Treatment Total Addressable Market (TAM)

6. Angioedema Treatment Market Segmentation

6.1. Global Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Allergic Angioedema
Drug-Induced Angioedema
Idiopathic Angioedema
Hereditary Angioedema (HAE)
6.2. Global Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injection
Oral
6.3. Global Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Research Organizations
6.4. Global Angioedema Treatment Market, Sub-Segmentation Of Allergic Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antihistamines
Corticosteroids
Epinephrine
Immunotherapy
Allergen Avoidance Therapies
6.5. Global Angioedema Treatment Market, Sub-Segmentation Of Drug-Induced Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Discontinuation of Causative Drug
Antihistamines
Corticosteroids
Epinephrine
Bradykinin Pathway Inhibitors
6.6. Global Angioedema Treatment Market, Sub-Segmentation Of Idiopathic Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Empirical Antihistamine Therapy
Corticosteroid Therapy
Leukotriene Receptor Antagonists
Monoclonal Antibodies
Observation And Symptom Management
6.7. Global Angioedema Treatment Market, Sub-Segmentation Of Hereditary Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
C1 Esterase Inhibitor Replacement Therapy
Bradykinin B2 Receptor Antagonists
Kallikrein Inhibitors
Attenuated Androgens
Antifibrinolytics

7. Angioedema Treatment Market Regional And Country Analysis

7.1. Global Angioedema Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Angioedema Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Angioedema Treatment Market

8.1. Asia-Pacific Angioedema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Angioedema Treatment Market

9.1. China Angioedema Treatment Market Overview
9.2. China Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Angioedema Treatment Market

10.1. India Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Angioedema Treatment Market

11.1. Japan Angioedema Treatment Market Overview
11.2. Japan Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Angioedema Treatment Market

12.1. Australia Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Angioedema Treatment Market

13.1. Indonesia Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Angioedema Treatment Market

14.1. South Korea Angioedema Treatment Market Overview
14.2. South Korea Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Angioedema Treatment Market

15.1. Western Europe Angioedema Treatment Market Overview
15.2. Western Europe Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Angioedema Treatment Market

16.1. UK Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Angioedema Treatment Market

17.1. Germany Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Angioedema Treatment Market

18.1. France Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Angioedema Treatment Market

19.1. Italy Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Angioedema Treatment Market

20.1. Spain Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Angioedema Treatment Market

21.1. Eastern Europe Angioedema Treatment Market Overview
21.2. Eastern Europe Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Angioedema Treatment Market

22.1. Russia Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Angioedema Treatment Market

23.1. North America Angioedema Treatment Market Overview
23.2. North America Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Angioedema Treatment Market

24.1. USA Angioedema Treatment Market Overview
24.2. USA Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Angioedema Treatment Market

25.1. Canada Angioedema Treatment Market Overview
25.2. Canada Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Angioedema Treatment Market

26.1. South America Angioedema Treatment Market Overview
26.2. South America Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Angioedema Treatment Market

27.1. Brazil Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Angioedema Treatment Market

28.1. Middle East Angioedema Treatment Market Overview
28.2. Middle East Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Angioedema Treatment Market

29.1. Africa Angioedema Treatment Market Overview
29.2. Africa Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Angioedema Treatment Market Competitive Landscape And Company Profiles

30.1. Angioedema Treatment Market Competitive Landscape
30.2. Angioedema Treatment Market Company Profiles
- 30.2.1. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

31. Angioedema Treatment Market Other Major And Innovative Companies

31.1. Bausch Health Companies Inc.
31.2. Apotex Inc.
31.3. Aurobindo Pharma Ltd.
31.4. Dr. Reddy's Laboratories Ltd
31.5. Cipla Inc.
31.6. Alnylam Pharmaceuticals Inc
31.7. Ionis Pharmaceuticals Inc.
31.8. Salix Pharmaceuticals Ltd
31.9. BioCryst Pharmaceuticals Inc.
31.10. Pharming Group NV
31.11. Pharvaris Netherlands B.V
31.12. Astria Therapeutics
31.13. Intellia Therapeutics
31.14. KalVista Pharmaceuticals Ltd.
31.15. ADARx Pharmaceuticals

32. Global Angioedema Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Angioedema Treatment Market

34. Recent Developments In The Angioedema Treatment Market

35. Angioedema Treatment Market High Potential Countries, Segments and Strategies

35.1 Angioedema Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Angioedema Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Angioedema Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer